Taro Pharmaceutical Industries Ltd. announced that its CEO, Mr. Kal Sundaram, has informed Taro’s Board of Directors (Board) of his intention to step down as CEO by the end of the current calendar year. Mr. Sundaram will return to India, to assume an executive position at Sun Pharma’s global headquarters after the completion of his assignment at Taro at the end of 2016. Mr. Sundaram will assist the Board with its search, and will remain with Taro through the end of 2016 to ensure a smooth and successful transition for his successor.